Abstract:The lack of effective chemical tools capable of dynamic tracking of labile glyoxal species (GOS) [e.g., methylglyoxal (MGO) and glyoxal (GO)] levels with high selectivity over other relevant electrophilic species, particularly, formaldehyde (FA) and nitric oxide (NO), has significantly hampered the understanding of their roles in a complex metabolic network and disease progressions. Herein, we report the rational design of the bioinspired 4-(2-guanidino)-1,8-naphthalimide fluorescent probes NAP-DCP-1 and NAP-DCP-3 from arginine-specific protein modifications. These probes undergo facile reversible fluorophore-promoted deprotonation–cyclization of a guanidium ion with labile GOS to form exocyclic five-membered dihydroxyimidazolidines. The probe NAP-DCP-1 can differentiate GOS levels in the serum of diabetic mice and patients from nondiabetic ones, which correlate very well with glucose levels, providing the GOS level as a potential new biomarker for diabetes diagnosis. Notably, the endoplasmic reticulum (ER)-targeting probe NAP-DCP-3 enabled the study of GOS perturbation in ER under various stress conditions and led to the discovery that formaldehyde (FA), either exogenously added or endogenously generated, could induce GOS level increases in ER. This finding reveals the previous unknown connection of FA with upregulated GOS levels and suggests that GOS is a key metabolite in bridging one-carbon metabolism with glycolysis and the downstream cell redox status. Moreover, the probes also showed potentials in separate quantification of MGO and GO via ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) and unexpected selectivity modulation for GO over MGO via two-photon excitation. It is expected that probes reported herein provide powerful tools to study GOS level modulations in complex biological networks and would facilitate GOS-associated basic research and discovery.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02447?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02447</a>.Supplemental experimental procedures, schemes, figures, images, UPLC-MS, NMR, and HRMS spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02447/suppl_file/ac0c02447_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Discovery of selective 2,4-diaminopyrimidine-based photoaffinity probes for glyoxalase i

Selectively lighting up glyoxal in living cells using an o-phenylenediamine fused hemicyanine

A Mitochondria-Targeting Water-Soluble Fluorescent Probe for Selective Detection of Glyoxal in Living Cells

Unraveling Potential Glyoxalase-I Inhibitors Utilizing Structure-Based Drug Design Techniques

Benzophenone and Its Analogs Bind to Human Glyoxalase 1

Fluorophore-Promoted Facile Deprotonation and Exocyclic Five-Membered Ring Cyclization for Selective and Dynamic Tracking of Labile Glyoxals

Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor

An Anthracenecarboximide-Guanidine Fluorescent Probe for Selective Detection of Glyoxals under Weak Acidic Conditions

Highly selective detection and imaging of glyoxal through a novel fluorescent probe

Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.

Imaging Tumorous Methylglyoxal by an Activatable Near-Infrared Fluorescent Probe for Monitoring Glyoxalase 1 Activity

A novel turn-on fluorescent probe for selective sensing and imaging of glutathione in live cells and organisms

Novel Covalent Probe Selectively Targeting Glutathione Peroxidase 4 In Vivo: Potential Applications in Pancreatic Cancer Therapy

Discovery of a Fluorogenic Probe for In Situ Pyruvate Kinase M2 Isoform (PKM2) Labeling through Chemoselective S N Ar with a Binding Site Lysine Residue

Discovery of New Glyoxalase I Inhibitors by Repurposing of FDA-approved Drugs: An in silico Study

One-step activated fluorescence bioimaging of γ-glutamyltransferase activity in living cancer cells based on chloro-rhodamine probe

Discovery of Potent and Selective Inhibitors against Protein-Derived Electrophilic Cofactors

Computational fragment-based drug design of potential Glo-I inhibitors

Site-specific Chemoproteomic Profiling of Targets of Glyoxal

Isoindoline-based fluorogenic probes bearing a self-immolative linker for the sensitive and selective detection of O-GlcNAcase activity

A mitochondria-targeted turn-on fluorescent probe for the detection of glutathione in living cells